Klosterneuburg, Austria

Randolf Kerschbaumer

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 70(Granted Patents)


Location History:

  • Vienna, AT (2005 - 2009)
  • Klosterneuberg, AT (2013)
  • Klosterneuburg, AT (2011 - 2022)

Company Filing History:


Years Active: 2005-2022

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Randolf Kerschbaumer: Innovator in Immunohistochemistry

Introduction

Randolf Kerschbaumer is a notable inventor based in Klosterneuburg, Austria. He has made significant contributions to the field of immunohistochemistry, holding a total of 16 patents. His work focuses on the detection of specific proteins, which has important implications in medical diagnostics.

Latest Patents

Among his latest patents is the invention titled "Anti-MIF immunohistochemistry." This invention pertains to the specific detection of MIF, particularly oxMIF, in tissues. The detection method utilizes immunohistochemistry and employs specific anti-oxMIF antibodies. Another significant patent is "Detection of CHO-MIF contaminations," which concerns a method for detecting complexes formed between antibodies and antigens that are endogenous to the production cell line, such as CHO MIF in a final product.

Career Highlights

Randolf Kerschbaumer has worked with prominent companies in the biotechnology sector, including Baxalta GmbH and Baxter Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative techniques in immunohistochemistry.

Collaborations

Throughout his career, Kerschbaumer has collaborated with esteemed colleagues, including Friedrich Scheiflinger and Gerhard Antoine. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Randolf Kerschbaumer's contributions to immunohistochemistry through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to impact medical diagnostics and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…